Past, present and future—-adrenoceptor agonists in asthma management
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Respiratory Medicine
- Vol. 99 (2) , 152-170
- https://doi.org/10.1016/j.rmed.2004.07.003
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Comparison of racemic albuterol and levalbuterol for treatment of acute asthmaThe Journal of Pediatrics, 2003
- Levalbuterol; pharmacologic properties and use in the treatment of pediatric and adult asthmaAnnals of Allergy, Asthma & Immunology, 2003
- Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterolAnnals of Allergy, Asthma & Immunology, 1999
- Pathophysiology of asthmaBritish Journal of Clinical Pharmacology, 1996
- Clinical pharmacology of long-acting β-receptor agonistsLife Sciences, 1993
- Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilatorLife Sciences, 1993
- The pharmacology of salmeterolLife Sciences, 1993
- Control of Asthma by AerosolsNew England Journal of Medicine, 1986
- Clinical effects of epinephrine by inhalationJournal of Allergy, 1948